This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Collingwood P Stephen: Innovator in Pharmaceutical Chemistry
Introduction
Collingwood P Stephen is a notable inventor based in Horsham, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the human body.
Latest Patents
Stephen holds a patent for "Pyrrolidinium derivatives as M3 muscarinic receptor antagonists." This patent describes compounds of formula (I) in salt or zwitterionic form, wherein R, R, R, and R have specific meanings as indicated in the specification. These compounds are useful for treating conditions mediated by the muscarinic M3 receptor. The patent also details pharmaceutical compositions that contain these compounds and a process for preparing them.
Career Highlights
Collingwood P Stephen is associated with Novartis AG, a leading global healthcare company. His work focuses on innovative solutions in drug development, contributing to advancements in medical treatments.
Collaborations
Stephen has collaborated with Neil John Press, enhancing the research and development efforts in their projects.
Conclusion
Collingwood P Stephen's contributions to pharmaceutical chemistry and his innovative patent work exemplify the impact of dedicated inventors in the healthcare industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile